FWM
BEAT

FSA Wealth Management’s BioTelemetry, Inc. BEAT Stock Holding History

FSA Wealth Management’s Portfolio BEAT Stock Details BEAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-80
Closed -$4K – 402
2020
Q2 		$4K Buy
+80
New +$3.58K ﹤0.01% 345

Other funds holding BEAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return

FSA Wealth Management's BEAT Position: Q3 2020 in Review

FSA Wealth Management sold out of BioTelemetry, Inc. (BEAT) in Q3 2020, closing a stake of 80 shares — an estimated $4K sold.

FSA Wealth Management first reported a position in BEAT in Q2 2020 and held it in 1 quarter. The position peaked at $4K in Q2 2020. 209 funds tracked by Wall St. Rank hold BEAT as of Q3 2020.

  • FSA Wealth Management reported no remaining BioTelemetry, Inc. position as of Q3 2020 after selling out during the quarter.
  • FSA Wealth Management sold 80 BioTelemetry, Inc. shares in Q3 2020, an estimated $4K.
  • FSA Wealth Management first reported a position in BioTelemetry, Inc. in Q2 2020 and held it in 1 quarter.
  • FSA Wealth Management's BioTelemetry, Inc. position peaked at $4K in Q2 2020.
  • 209 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q3 2020.

Based on FSA Wealth Management's 13F filing for Q3 2020, filed 13 Nov 2020.